The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders

Antiretroviral therapy has dramatically improved the lives of human immunodeficiency virus 1 (HIV-1) infected individuals. Nonetheless, HIV-associated neurocognitive disorders (HAND), which range from undetectable neurocognitive impairments to severe dementia, still affect approximately 50% of the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mediouni, Sonia, Garibaldi Marcondes, Maria Cecilia, Miller, Courtney, McLaughlin, Jay P., Valente, Susana T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615951/
https://www.ncbi.nlm.nih.gov/pubmed/26557111
http://dx.doi.org/10.3389/fmicb.2015.01164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615951/
https://www.ncbi.nlm.nih.gov/pubmed/26557111
http://dx.doi.org/10.3389/fmicb.2015.01164

Ejemplares similares